Search

In this study, a novel Pseudomonas phage, vB_PaeS_VL1 (VL1), was isolated from urban sewage. Phylogenetic analyses revealed that VL1 is a novel species in the genus Litunavirus of subfamily Migulavirinae. The VL1 is a virulent phage as no g

In this paper, Nale et al. review current progress in Clostridioides difficile phage research. They discuss tested strategies of isolating C. difficile phages directly, and via enrichment methods from various sample types and through antibi

From Phase Genomics via Twitter: Milestone alert! We’re celebrating 150+ papers published using our tech. And there’s a lot to share: our clients made breakthroughs in a broad range of fields from metagenomics to oncology. Here’s a look at

Check out this youtube video of Rob Lavigne’s Phage Oxford 2022 talk.

In a new paper in PLOS Computational Biology, Quentin J. Leclerc (Institut Pasteur) and colleagues use mathematical modelling to investigate the conditions under which phages and antibiotics act in synergy to remove bacteria or drive antimi

A new preprint by Madison Stellfox (University of Pittsburgh) and colleagues reports on the use of phage therapy to treat recurrent E. faecium bloodstream infections in a patient.

A new paper in Nature Communications by Lei Tian (McMaster University) and colleagues describes a new method for producing phage microgels, which could be used as sprayable antimicrobials targeting multidrug-resistant bacteria.

The UK Government's Commons Science and Technology Committee announces the terms of reference for a new inquiry exploring the potential of bacteriophages as an alternative to antibiotics.

In a new opinion piece in the Boston Globe, Kevin Outterson and Henry Skinner discuss the global threat of antibiotic resistance.

McMaster University researchers (Lei Tian, Zeinab Hosseinidoust and colleagues) crosslinked half a million filamentous phages into each soft microgel, producing over 35,000 microgels per square centimetre of film template, a 13-billion-phag

Phages for Global Health is planning to deliver hands-on phage workshops in Africa and Asia again, with a new curriculum that incorporates the best parts of the virtual teaching from the past year into an updated workshop curriculum with 2

The Africa Phage Forum will be hosting a webinar on December 6th, 2022 at 3:00 PM East Africa Time (EAT) or 12 PM GMT. The webinar, titled 'Safety Evaluation of Phages Infecting Carbapenem-Resistant Klebsiella pneumoniae for Therapy in Low-

The FDA approved Rebyota, the first fecal microbiota product, for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. Rebyota is administered rectally as a single dose and is pr

Innovate UK KTN has launched the Phage Innovation Network to drive innovation in the regulation and development of phage technologies for applications across multiple sectors, ensuring the UK maintains its strong stance on tackling antimicr

In a new paper in Viruses, Fedor Zurabov (MicroMir, Russia) and colleagues report that phage cocktails were safely administered to thirty patients after COVID-19.

In a new paper in Viruses, Maik Wolfram-Schauerte and colleagues (Max-Planck-Institute for Terrestrial Microbiology) apply transcriptomics and proteomics to characterize the temporal patterns of transcription and protein synthesis during T4

Panagiotis Zagaliotis (Weill Cornell Medicine New York) and colleagues published a new review in Pathogens and Immunity on the therapeutic phages for Gram-negative bacterial infections in animals and humans.

The 3rd International Conference on Bacteriophage Research and Antimicrobial Resistance (ICBRAR – 2022) will be held on 26 & 27 November 2022 at Karnatak University Dharwad in India.

Eligo Bioscience just announced the issuance by the US Patent and Trademark Office of the first patent in a wide family covering genetic engineering of Cutibacterium acnes to support therapeutic interventions in multiple serious skin disord

In this opinion piece for USA Today, Mallory Smith's mother, Diane Shader Smith, describes her daughter's preventable death from a drug resistant infection, and reflects on the opportunity that currently exists for US Congress to pass the P